Blincyto – Blinatumomab uses, dose and side effects
The active substance in BLINCYTO is blinatumomab. It belongs to a group of drugs called cytostatic / cytotoxic drugs that target cancer cells.
Read MoreThe active substance in BLINCYTO is blinatumomab. It belongs to a group of drugs called cytostatic / cytotoxic drugs that target cancer cells.
Read More© 2022. All Rights Reserved